Trending Now
The UK Government To Purchase 60 Million Doses of NVX-CoV2373 Through...
Novavax, Inc. (NASDAQ:NVAX) and the UK government will be collaborating on Phase 3 clinical trial in the UK. The company has signed a Heads...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Sarepta Therapeutics Inc. (NASDAQ: SRPT) Reports Preliminary Q3 2021 Results And...
Sarepta Therapeutics Inc. (NASDAQ: SRPT) has announced its preliminary Q3 2021 financial results. The company expects net product revenues of $166.9 million relative to...
MAKE IT MODERN
LATEST REVIEWS
Moderna (NASDAQ: MRNA) Receives Emergency Use Authorization For Its COVID-19 Vaccine...
Moderna (NASDAQ: MRNA) has received approval from the Philippines Food and Drug Administration for its coronavirus vaccine for children between 12 and 17 years.
The...
MAKE IT MODERN
PERFORMANCE TRAINING
Could this Small Food Delivery Start-Up be Lined up for Acquisition Interest? (TWOH, UBER,...
Acquisition potential is a major factor driving capital allocation. One space that has started to show signs of a potential wave of...
Wall Street’s Top Stock Picks for the Week: From Tesla (TSLA) to Getty (GETTY)
As we navigate through another bustling week on Wall Street, several major analysts and banks have made significant calls regarding some...
AnPac Bio-Medical Science Co Ltd – A.D.R. (NASDAQ: ANPC) Appoints Mr. Chao Feng as...
AnPac Bio-Medical Science Co Ltd - A.D.R. (NASDAQ: ANPC) recently announced that Mr. Chao Feng has been appointed as an independent director effective July...
Altimmune Inc (NASDAQ:ALT) Says the Multiple Dose Toxicity and Toxicokinetic Studies of ALT-801 Were...
Altimmune Inc (NASDAQ:ALT) is continuously pursuing the development of immune-modulating therapies, the primary focus being treatments for liver disease. In its diverse pipeline, the...
Icosavax Inc (NASDAQ: ICVX) Has Positive Results For the Phase I/II IVX-411 Study
Icosavax Inc (NASDAQ: ICVX) announced that it had received positive topline results for IVX-411 in Phase I/II study. The drug is a potential vaccine...
MAKE IT MODERN
